Meningococcal disease

History of Vaccines Blog


Only Two Doses of HPV Vaccine Needed for Younger Adolescents

October 20, 2016

Human papillomavirus vaccination series completion will now require only two doses of vaccine for adolescents younger than 15 years. The Advisory Committee on Immunization Practices approved this recommendation at their biannual meeting in Atlanta yesterday. The new schedule for <15 year olds calls for the second dose to be given between 6 and 12 months after the first dose. Adolescents receiving the first dose of HPV vaccine at age 15 or older will continue to be recommended three doses of vaccine, given at 0, 1-2, and 6 months.

ACIP Makes New Tdap and Meningococcal Vaccine Recommendations

October 26, 2012

Today's blog post is by Andreas Bollmann, MD, PhD, FAAP, a Philadelphia-area pediatrician and History of Vaccines advisor.

Serogroup B Meningococcal Disease at University of Oregon

March 19, 2015

Neisseria meningitidis, x3750. Copyright Dennis KunkelSix cases of disease from serogroup B meningococcal bacteria have occurred at the University of Oregon since January; the latest case was confirmed just today.

College Meningitis B Outbreaks and a New Vaccine

January 29, 2014

Bexsero, courtesy NovartisAfter eight cases of group B meningococcal disease at Princeton University and four cases at University of California, Santa Barbara, health authorities have taken an unusual pathway to using a vaccine that is not licensed in the United States. 

Notes from Vaccine Update Webinar with Paul Offit, MD

March 14, 2013

On March 13, the Children’s Hospital of Philadelphia Vaccine Education Center sponsored a vaccine update webinar with Paul A. Offit, MD, as the speaker and moderator. Dr. Offit discussed items in the news related to vaccines as well as decisions taken at recent Advisory Committee on Immunization Practices (ACIP) meetings in Atlanta.